Cargando…
Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours
Cancer drug therapies are only effective in a small proportion of patients. To make things worse, our ability to identify these responsive patients before administering a treatment is generally very limited. The recent arrival of large-scale pharmacogenomic data sets, which measure the sensitivity o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722542/ https://www.ncbi.nlm.nih.gov/pubmed/29228590 http://dx.doi.org/10.18632/oncotarget.20923 |